Vanguard Capital Management’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
Other funds holding CTXR
BFCFS
Vanguard Capital Management's CTXR Position: Q3 2026 in Review
Vanguard Capital Management increased its Citius Pharmaceuticals (CTXR) stake by 34% in Q3 2026, buying an estimated $39.7K and bringing the position to 264,672 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #3815.
Vanguard Capital Management first reported a position in CTXR in Q1 2026 and has held it in 3 quarters since. The position peaked at $151K in Q1 2026. 34 funds tracked by Wall St. Rank hold CTXR as of Q3 2026.
- Vanguard Capital Management held 264,672 shares of Citius Pharmaceuticals worth $141K as of Q3 2026.
- Vanguard Capital Management bought 67,308 Citius Pharmaceuticals shares in Q3 2026, an estimated $39.7K.
- Citius Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3815 holding.
- Vanguard Capital Management first reported a position in Citius Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Citius Pharmaceuticals position peaked at $151K in Q1 2026.
- 34 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.